Wednesday 4th July

9.00 – Biomarkers – Pietro Spitali and Andreas Roos

10.00 – Showcase: validation of MRI as a biomarker in clinical trials – Volker Straub


11.00 – Coffee/tea


11.30 – Showcase: PROM development – Nathalie Goemans


12.15 – Lunch


13.15 – Clinical trial practicality forum – moderated by Annemieke Aartsma-Rus and Teresinha Evangelista

16.30 – After approval: Proms and HTA – TBC

17.30 – End of day 3

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern